2,3-Dibromopropionamide → 4-(3-Chlorophenyl)-1-[(3,4-dimethoxyphenyl)methyl]-2-piperazinecarboxamide

HRID 1588990노트

반응식

HRID 1588990 반응식
[Cl:1][C:2]1[CH:3]=[C:4]([NH:8][CH2:9][CH2:10][NH:11][CH2:12][C:13]2[CH:18]=[CH:17][C:16]([O:19][CH3:20])=[C:15]([O:21][CH3:22])[CH:14]=2)[CH:5]=[CH:6][CH:7]=1.Br[CH:24]([CH2:28]Br)[C:25]([NH2:27])=[O:26]>>[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[CH2:9][CH2:10][N:11]([CH2:12][C:13]3[CH:18]=[CH:17][C:16]([O:19][CH3:20])=[C:15]([O:21][CH3:22])[CH:14]=3)[CH:24]([C:25]([NH2:27])=[O:26])[CH2:28]2)[CH:5]=[CH:6][CH:7]=1

참가 물질

3

실험 절차

In a manner similar to Preparation 1, react N-(3-chlorophenyl)-N'-[(3,4-dimethoxyphenyl)methyl]-1,2-ethanediamine (13.3 g, 41 mmol) with 2,3-dibromopropanamide (19.1 g, 166 mmol) to obtain the title compound.

후처리

  1. customIn a manner similar to Preparation 1

출처 및 근거

ORD 기록
ord-3d44094663384c79ae3de578305b961d
출처 데이터셋
uspto-grants-1993_06
특허 번호
US05223623

반응 노트

불러오는 중…